Sangamo Therapeutics
SGMO
#5302
Rank
$0.60 B
Marketcap
$3.67
Share price
3.09%
Change (1 day)
-35.50%
Change (1 year)

Operating Margin for Sangamo Therapeutics (SGMO)

Operating Margin as of February 2023 (TTM): -160.78%

According to Sangamo Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -160.78%. At the end of 2021 the company had an Operating Margin of -160.79%.

Operating Margin history for Sangamo Therapeutics from 2013 to 2012

Operating Margin at the end of each year

Year Operating Margin Change
2021-160.79%57.34%
2020-102.19%9.69%
2019-93.16%14.2%
2018-81.57%-45.34%
2017-149.23%-59.63%
2016-369.65%214.82%
2015-117.42%103.88%
2014-57.59%-47.8%
2013-110.32%7.3%
2012-102.81%-70.38%
2011-347.14%189.64%
2010-119.85%37.05%
2009-87.45%-44.22%
2008-156.77%-42.42%
2007-272.27%3.57%
2006-262.89%-52.5%
2005-553.46%-50.32%
2004-1,114.07%144.13%
2003-456.34%-36.47%
2002-718.26%128.15%
2001-314.82%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
24.28%-100.03%๐Ÿ‡บ๐Ÿ‡ธ USA
29.35%-100.03%๐Ÿ‡บ๐Ÿ‡ธ USA
32.74%-100.02%๐Ÿ‡บ๐Ÿ‡ธ USA
12.36%-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
16.73%-100.02%๐Ÿ‡บ๐Ÿ‡ธ USA
28.49%-100.03%๐Ÿ‡บ๐Ÿ‡ธ USA
-100.93%-100.18%๐Ÿ‡บ๐Ÿ‡ธ USA
5.00%-100.06%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.